Viewing Study NCT04107961


Ignite Creation Date: 2025-12-24 @ 12:37 PM
Ignite Modification Date: 2026-01-26 @ 4:09 AM
Study NCT ID: NCT04107961
Status: WITHDRAWN
Last Update Posted: 2022-09-30
First Post: 2019-09-23
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Assess Safety and Efficacy of a Leishmania Vaccine to Prevent Post Kala Azar Dermal Leishmaniasis (PKDL)
Sponsor: University of York
Organization:

Study Overview

Official Title: A Phase II Study to Assess the Safety and Efficacy of the Leishmania Vaccine ChAd63-KH for the Prevention of Post-kala Azar Dermal Leishmaniasis
Status: WITHDRAWN
Status Verified Date: 2022-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: The trial will be undertaken but the protocol will be substantially revised.
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: LEISH3
Brief Summary: The actual format of the anticipated LEISH3 trial is under review.
Detailed Description: The leishmaniases are poverty-related neglected diseases with a major impact on health worldwide. They affect the poorest of the poor and present a severe barrier to socio-economic development. Caused by infection with one of several species of Leishmania parasite, these diseases occur in 98 countries worldwide and can be broadly classified as tegumentary leishmaniases (TL; affecting the skin and mucosa) and visceral leishmaniasis (VL; affecting internal organs). Worldwide, over 1 million reported cases of TL and 0.5 million reported cases of VL occur each year. Whereas TL are chronic and non-life-threatening, VL is responsible for over 20,000 deaths per year, second only to malaria amongst parasites with regard to mortality. Collectively, approximately 2.4 million disability-adjusted life years are lost to the leishmaniases. No vaccines are currently licensed for any form of human leishmaniasis and the drug arsenal is limited and increasingly compromised by drug resistance.

.

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: